B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Basic principles of toxicology, toxicology of the immune system, relevance to immunosafety |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Definition, history and application of immunosafety in drug development |
|
Enduring |
|
$25.00 |
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity |
|
Enduring |
|
$25.00 |
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
Animal models and species differences (immune system) |
|
Enduring |
|
$25.00 |
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
Basic immunology: complement and hypersensitivities |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |